Immersive virtual reality program to boost well-being in older adults in long-term care

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial examines the acceptability and potential benefits of an immersive VR protocol called Well-being RRCE for older adults without cognitive impairment in long-term care. Participants are randomized to active VR with reminiscence, relaxation, and cultural experiences, passive VR exposure to non-interactive environments, or usual care. The active intervention uses small groups over four weeks with 20-minute sessions, and sessions are recorded for exploratory analysis of emotional responses. A pilot with 12 participants supported feasibility and safety, informing the current total target of 60 participants across three facilities in Sevilla, Spain.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Age ≥ 60 years
2. Residence in a long-term care facility for at least 3 months
3. Absence of significant cognitive impairment (MMSE ≥ 21)
4. Able to provide informed consent or have a legal representative who can do so. (5 )Able to remain seated for approximately 20 minutes per session.

(6) Willing to participate in 12 VR sessions over four weeks.

Exclusion Criteria:

1. Cognitive impairment that prevents understanding instructions or interacting with VR content.
2. Severe psychopathological diagnosis or active psychiatric disorder requiring acute clinical management.
3. Severe sensory impairments.
4. Medical or neurological conditions that contraindicate VR exposure (e.g., uncontrolled epilepsy, severe motion sickness).
5. Acute medical instability or conditions requiring urgent clinical intervention.
6. Any condition judged by clinical staff to pose a safety risk during VR immersion.

Where it's running

• Residencia San Juan de Dios
  Bormujos, Sevilla, Spain Recruiting
• The intervention is implemented across three long-term care facilities located in Sevilla, Spain.
  Seville, Spain Not yet recruiting

Study contacts

• Study coordinator: Francisco Antonio Nieto-Escamez, PhD
• Email: pnieto@ual.es
• Phone: +34 950214628

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Youniqor safety and tolerability in healthy older adults

  This will test whether taking the nutritional supplement Youniqor daily for 8 weeks is safe and well tolerated by healthy adults aged 60 to 80.

  Recruiting Yoxlo B.v. · Pune, Maharashtra · NCT07442097

• Elamipretide to improve physical function and healthy aging

  This study will try daily elamipretide injections for four weeks to see if the drug is safe and improves mobility, thinking, and blood inflammation markers in older adults with lower physical function.

  Recruiting Phase 2 University of Washington · Seattle, Washington · NCT07275424

• Study on physical and cognitive aging in older Hispanic adults

  This study is trying to see how physical activity and thinking skills change over time in older Hispanic adults to understand aging better.

  Recruiting University of Florida · Jacksonville, Florida · NCT06726616

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.